Compare Expedia Group Inc (EXPE) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expedia Group Inc vs Cassava Sciences Inc — how do they compare? Expedia Group Inc trades at $321 (market cap $38.53B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Expedia Group Inc is far larger — about 806.9× Cassava Sciences Inc's market cap, and Expedia Group Inc pays a 0.6% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| EXPE | FLNA | |
|---|---|---|
Market Cap | $38.53B | $47.75M |
Sector | Consumer Cyclical | Health |
52-Week High | $321.07 | $4.64 |
52-Week Low | $188.51 | $0.87 |
Enterprise Value | $37.09B | -$34.93M |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
